<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192656</url>
  </required_header>
  <id_info>
    <org_study_id>BTCHENT201901</org_study_id>
    <nct_id>NCT04192656</nct_id>
  </id_info>
  <brief_title>The Effect of PAP on ISSHL Comorbided With OSA</brief_title>
  <official_title>The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tsinghua Chang Gung Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tsinghua Chang Gung Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical randomized controlled study is to explore the effect of positive airway
      pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both
      idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep
      apnea(OSA) between Dec. 2019 to Dec. 2029.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">December 2029</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hearing threshold</measure>
    <time_frame>3 months after onset of ISSHL</time_frame>
    <description>the recovery of hearing threshold which will be measured by pure tone audiometry</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Sudden Hearing Loss</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>PAP plus medication</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients treated by both PAP and medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medication</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients treated by medication only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non-invasive positive airway pressure</intervention_name>
    <description>non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea</description>
    <arm_group_label>PAP plus medication</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone Hemisuccinate</intervention_name>
    <description>Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss</description>
    <arm_group_label>PAP plus medication</arm_group_label>
    <arm_group_label>medication</arm_group_label>
    <other_name>Methylprednisolone, MP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginaton</intervention_name>
    <description>ginnaton is ginkgo biloba extract</description>
    <arm_group_label>PAP plus medication</arm_group_label>
    <arm_group_label>medication</arm_group_label>
    <other_name>Ginkgo biloba extract,GBE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. aged &gt;= 18 and &lt;= 70,

          2. diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012
             criteria, and AHI &gt; 15/h,

          3. diagnosed with ISSHL by AAO-HNS 2019 criteria,

          4. ISSHL onset within 1 week.

        Exclusion Criteria:

          1. sudden hearing loss with certain causes,

          2. with severe comorbid diseases,

          3. pregnant or breast-feeding women,

          4. AHI &lt;= 15/h,

          5. hearing threshold recovered &gt; 50% when included,

          6. previously regularly treated with PAP.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juanjuan Gao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tsinghua Changung Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>jingying Ye, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Tsinghua Changung Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Haijin Yi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Tsinghua Changung Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mu He, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tsinghua Changung Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xin Cao, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tsinghua Changung Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xingxing Lu, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tsinghua Changung Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sichao Liang, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tsinghua Changung Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jingying Ye, MD</last_name>
    <phone>+86-13701396970</phone>
    <email>yejingying@163.vip.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haijin Yi, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Tsinhgua Changgung Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100028</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xin Cao</last_name>
      <phone>86-15810519277</phone>
      <email>caoxin19860201@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Mu He</last_name>
      <phone>86-15210588954</phone>
      <email>muhe2009@qq.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Hızlı Ö, Özcan M, Ünal A. Evaluation of comorbidities in patients with OSAS and simple snoring. ScientificWorldJournal. 2013 Apr 18;2013:709292. doi: 10.1155/2013/709292. Print 2013.</citation>
    <PMID>23710145</PMID>
  </reference>
  <reference>
    <citation>Kayabasi S, Iriz A, Cayonu M, Cengiz B, Acar A, Boynuegri S, Mujdeci B, Eryilmaz A. Vestibular functions were found to be impaired in patients with moderate-to-severe obstructive sleep apnea. Laryngoscope. 2015 May;125(5):1244-8. doi: 10.1002/lary.25021. Epub 2014 Nov 12.</citation>
    <PMID>25388224</PMID>
  </reference>
  <reference>
    <citation>Casale M, Vesperini E, Potena M, Pappacena M, Bressi F, Baptista PJ, Salvinelli F. Is obstructive sleep apnea syndrome a risk factor for auditory pathway? Sleep Breath. 2012 Jun;16(2):413-7. doi: 10.1007/s11325-011-0517-x. Epub 2011 Apr 9.</citation>
    <PMID>21479758</PMID>
  </reference>
  <reference>
    <citation>Fu Q, Wang T, Liang Y, Lin Y, Zhao X, Wan J, Fan S. Auditory Deficits in Patients With Mild and Moderate Obstructive Sleep Apnea Syndrome: A Speech Syllable Evoked Auditory Brainstem Response Study. Clin Exp Otorhinolaryngol. 2019 Feb;12(1):58-65. doi: 10.21053/ceo.2018.00017. Epub 2018 Aug 24.</citation>
    <PMID>30134647</PMID>
  </reference>
  <reference>
    <citation>Sheu JJ, Wu CS, Lin HC. Association between obstructive sleep apnea and sudden sensorineural hearing loss: a population-based case-control study. Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):55-9. doi: 10.1001/archoto.2011.227.</citation>
    <PMID>22249630</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>December 9, 2019</last_update_submitted>
  <last_update_submitted_qc>December 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tsinghua Chang Gung Hospital</investigator_affiliation>
    <investigator_full_name>Ye Jingying</investigator_full_name>
    <investigator_title>Director of the dept. of Otolaryngology, Head and Neck Surgery, and Director of the Center of Sleep Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Sudden</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

